BioSpace News Archive

Policy

Canadian Cancer Society calls on all federal parties to make cancer a priority this election

The Canadian Cancer Society is urging political party leaders to make cancer a priority this federal election.

June 27, 2019
·
3 min read
BioMidwest

Easterseals Receives $230,000 In Grants From The Comcast NBCUniversal Foundation To Leverage Technology That Creates Opportunities For People With Disabilities

Grant Announced as Easterseals Celebrates 100 Years of Service and Impact in the Lives of People with Disabilities

June 27, 2019
·
6 min read
Policy

IncellDx Awarded Patent for Blood Collection Tube (BCT) That Activates HIV from Latent Cellular Reservoirs in the Tube

IncellDx, a leading single cell cancer diagnostics company, announced the issuing of a US patent for a blood collection tube that stimulates dormant HIV to produce virus in the infected cells while in the blood collection tube.

June 27, 2019
·
1 min read
Business

Canopy Growth and Acreage Implement Previously Announced Plan of Arrangement

Acreage Holdings, Inc. and Canopy Growth Corporation are pleased to announce the implementation of Acreage’s previously announced arrangement under section 288 of the Business Corporations Act with Canopy Growth.

June 27, 2019
·
10 min read
Pharm Country

NYU Langone Health Launches New Center to Study the Drivers and Consequences of the National Opioid Epidemic

Watch a video of Dr. Magdalena Cerdá outline the mission and goals of the Center for Opioid Epidemiology and Policy

June 27, 2019
·
5 min read
Drug Development

Sierra Oncology Launches Campaign Exploring Non-Dilutive Strategic Options to Support Development of its DDR Assets

Sierra Oncology, Inc. announced plans to prioritize its existing resources on the development of momelotinib, its differentiated Phase 3 drug candidate for the treatment of patients with myelofibrosis.

June 27, 2019
·
7 min read
FDA

LifeMax Receives Orphan Drug Designation From the United States Food & Drug Administration For LM-030 For The Treatment of Netherton Syndrome

LifeMax Laboratories, Inc. announced that the Food & Drug Administration granted orphan drug designation to LM-030, an investigational therapy licensed from Novartis and ready to enter into pivotal clinical trials for the treatment of Netherton Syndrome.

June 27, 2019
·
2 min read
Policy

Acerus Provides Update On Avanafil Health Canada Submission

Acerus Pharmaceuticals Corporation announced that Health Canada has completed the initial screening process for the previously announced New Drug Submission for avanafil.

June 27, 2019
·
4 min read
Deals

Walgreens Boots Alliance Reports Fiscal 2019 Third Quarter Results

Walgreens Boots Alliance, Inc. announced financial results for the third quarter of fiscal 2019, which ended May 31, 2019.

June 27, 2019
·
15 min read
Deals

Blue Earth Diagnostics to be Acquired by Global Leader Bracco Imaging

Blue Earth Diagnostics, a molecular imaging diagnostics company, announced that a definitive agreement has been signed for Bracco Imaging S.p.A.

June 27, 2019
·
8 min read